Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001437749-25-036389
Filing Date
2025-11-26
Accepted
2025-11-26 08:58:09
Documents
26

Document Format Files

Seq Description Document Type Size
1 FORM S-3 pyxs20251125_s3.htm   iXBRL S-3 521248
2 EXHIBIT 1.2 ex_893483.htm EX-1.2 267713
3 EXHIBIT 4.1 ex_893482.htm EX-4.1 405584
4 EXHIBIT 5.1 ex_893455.htm EX-5.1 41249
5 EXHIBIT 5.2 ex_893454.htm EX-5.2 13493
6 EXHIBIT 23.2 ex_893453.htm EX-23.2 2442
7 EXHIBIT FILING FEES ex_893452.htm   iXBRL EX-FILING FEES 37544
12 pyxislogo.jpg GRAPHIC 5631
13 sidley.jpg GRAPHIC 4832
  Complete submission text file 0001437749-25-036389.txt   1792812

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA pyxs-20251231.xsd EX-101.SCH 5412
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pyxs-20251231_def.xml EX-101.DEF 12111
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE pyxs-20251231_lab.xml EX-101.LAB 26026
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pyxs-20251231_pre.xml EX-101.PRE 12390
28 EXTRACTED XBRL INSTANCE DOCUMENT pyxs20251125_s3_htm.xml XML 2828
29 EXTRACTED XBRL INSTANCE DOCUMENT ex_893452_htm.xml XML 10149
Mailing Address 321 HARRISON AVENUE BOSTON MA 02118
Business Address 321 HARRISON AVENUE BOSTON MA 02118 (617) 221-9059
Pyxis Oncology, Inc. (Filer) CIK: 0001782223 (see all company filings)

EIN.: 831160910 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-291801 | Film No.: 251524790
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)